Cargando…
A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness
Recently, the highly mutated oncoprotein K-Ras4B (hereafter K-Ras) was shown to drive cancer cell stemness in conjunction with calmodulin (CaM). We previously showed that the covalent CaM inhibitor ophiobolin A (OphA) can potently inhibit K-Ras stemness activity. However, OphA, a fungus-derived natu...
Autores principales: | Okutachi, Sunday, Manoharan, Ganesh Babu, Kiriazis, Alexandros, Laurini, Christina, Catillon, Marie, McCormick, Frank, Yli-Kauhaluoma, Jari, Abankwa, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8296985/ https://www.ncbi.nlm.nih.gov/pubmed/34307350 http://dx.doi.org/10.3389/fcell.2021.665673 |
Ejemplares similares
-
Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells
por: Manoharan, Ganesh Babu, et al.
Publicado: (2022) -
K-Ras Binds Calmodulin-Related Centrin1 with Potential Implications for K-Ras Driven Cancer Cell Stemness
por: Manoharan, Ganesh babu, et al.
Publicado: (2023) -
PDE6D Inhibitors
with a New Design Principle Selectively
Block K-Ras Activity
por: Siddiqui, Farid A., et al.
Publicado: (2019) -
Mechanism of the Oxidation
of Heptafulvenes to Tropones
Studied by Online Mass Spectrometry and Density Functional Theory
Calculations
por: Nilsson, Sofia M. E., et al.
Publicado: (2019) -
Editorial: Computational Resources for Understanding Biomacromolecular Covalent Modifications
por: Xue, Yu, et al.
Publicado: (2021)